1. The developability classification system: application of biopharmaceutics concepts to formulation development;Butler;J Pharm Sci,2010
2. Approaches for establishing clinically relevant dissolution specifications for immediate release solid oral dosage forms;Hermans;AAPS J,2017
3. CDER/FDA. M9 biopharmaceutics classification systembased biowaivers: guidance for industry; 2021. https://www.fda.gov/drugs/guidance-compliance-regulatory-information/guidances-drugs
4. CDER/FDA. Waiver of in vivo bioavailability and bioequivalence studies for immediate-release solid oral dosage forms based on a biopharmaceutics classification system: guidance for industry. Published online 2017:1–16. https://www.fda.gov/drugs/guidances-drugs/all-guidances-drugs
5. Study of different crystal habits of aprepitant : dissolution and material attributes;Datir;Appl Sci,2021